Amount Raised
$210 Million
Round Type
Funding Round
ChinaBiotechnologyPharmaceuticalBiopharmaInvestors
Description
On November 20, 2023, Viva Biotech Holdings Group (1873. HK) announced that it completed a funding round, securing approximately US$210 million and bringing in the strategic investors, Temasek, Highlight Capital (HLC), and True Light. Following this transaction, the Viva Biotech Holdings group obtained financing of nearly US$150 million through the transfer of approximately 24.21% equity in its CRO business entity, Viva Biotech (Shanghai) Limited. Before, the publicly listed company at the group level had already secured approximately US$ 60 million in convertible bond financing, which will be automatically converted into shares at the price of 2.0 HKD/share on the delivery date.
Who else raised in Pharmaceutical and Biopharma around the same time
Companies in the same sectors as Viva Biotech that raised within 45 days of this round, from Fundz verified event records.
- OnCusp Therapeutics raised $100M (Series A) on January 4, 2024.
- Apollo Therapeutics Group Limited raised an undisclosed amount (Series C) on January 2, 2024.
- Biodexa Pharmaceuticals raised $6.8M on December 21, 2023.
- Os Therapies raised $700K on December 8, 2023.
- Forward Therapeutics raised $50M (Series A) on November 8, 2023.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
Who to call at Viva Biotech, and when
A new round usually means Viva Biotech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Viva Biotech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Viva Biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Viva Biotech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Viva Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Viva Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.